Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/europace/eus358 | DOI Listing |
Heart Rhythm
September 2024
Division of Cardiology, Section of Electrophysiology, Emory University School of Medicine, Atlanta, Georgia. Electronic address:
Background: Lead-related venous stenosis and occlusion can complicate the insertion or replacement of transvenous leads in patients with cardiac implantable electronic devices (CIEDs). A possible solution is to tunnel the lead from the contralateral vasculature to the ipsilateral generator. Procedural complications and long-term outcomes remain unclear with this technique.
View Article and Find Full Text PDFIndian Pacing Electrophysiol J
September 2024
Almazov National Medical Research Center, 197341, 2, Akkuratova St., Saint-Petersburg, Russian Federation.
We present a case of successful implantation of a cardioverter-defibrillator (ICD) using combined technique in a child with Timothy's syndrome. Due to high risk of sudden cardiac death (SCD) such patients often need ICD for primary or secondary prevention but implantation technique in young children remains controversial. The subcutaneous cardioverter-defibrillators could be an option in some cases, however, reliable cardiac pacing should be implemented for patients with bradyarrhythmias.
View Article and Find Full Text PDFJ Cardiovasc Electrophysiol
March 2024
Arrhythmia and Electrophysiology Center, IRCCS Multimedica, Milan, Italy.
The subcutaneous implantable cardioverter defibrillator (S-ICD) was developed as an alternative to the traditional transvenous implantable cardioverter defibrillator (TV-ICD), aiming to provide easier implantation, simplified detection algorithm of malignant ventricular arrhythmias and prevention from placing components in the cardiovascular system. The S-ICD is implanted subcutaneously or intramuscularly with the generator placed in the left midaxillary line and the lead tunneled subcutaneously in the left para-sternal region. Preimplant electrocardiogram screening is recommended to prevent implantation in patients at high risk of T wave over-sensing.
View Article and Find Full Text PDFHeart
July 2022
Department of Medicine, Division of Cardiology, University of California San Francisco, San Francisco, California, USA
Objective: This tertiary centre study aims to identify factors associated with adverse outcomes in adult survivors with total cavopulmonary connection (TCPC) Fontan palliation for single ventricle.
Methods: This retrospective review of medical records identified adult (≥18 years) survivors of TCPC Fontan palliation who were followed at a single tertiary centre between 1 January 2000 and 1 July 2019. Adverse outcomes were defined as arrhythmia, pacemaker/implantable cardioverter defibrillator placement, liver cirrhosis, protein losing enteropathy, hospitalisation for heart failure, thromboembolic complication and/or death.
HeartRhythm Case Rep
August 2021
Dallas Medical Physician Group and Baylor Scott & White, The Heart Hospital-Plano, Plano, Texas.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!